{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:22:01Z","timestamp":1790742121847,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"28","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.vaccine.2018.05.098","type":"journal-article","created":{"date-parts":[[2018,5,30]],"date-time":"2018-05-30T14:57:11Z","timestamp":1527692231000},"page":"4046-4053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical features and outcomes of Bacille Calmette-Gu\u00e9rin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization"],"prefix":"10.1016","volume":"36","author":[{"given":"Rattanachai","family":"Rermruay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supattra","family":"Rungmaitree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunsanee","family":"Chatpornvorarux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantapat","family":"Brukesawan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orasri","family":"Wittawatmongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keswadee","family":"Lapphra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanatpreeya","family":"Phongsamart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nantaka","family":"Kongstan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjawan","family":"Khumcha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kulkanya","family":"Chokephaibulkit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.vaccine.2018.05.098_b0005","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1136\/archdischild-2013-304457","article-title":"Fifteen-minute consultation: Bacillus Calmette-Gu\u00e9rin abscess and lymphadenitis","volume":"99","author":"Riordan","year":"2014","journal-title":"Arch Dis Child Educ Pract Ed"},{"key":"10.1016\/j.vaccine.2018.05.098_b0010","unstructured":"World Health Organization. Information sheet observed rate of vaccine reactions Bacille Calmette-Gu\u00e9rin (BCG) vaccine. April, 2012. http:\/\/www.who.int\/vaccine_safety\/initiative\/tools\/BCG_Vaccine_rates_information_sheet.pdf [accessed 31.10.17]."},{"key":"10.1016\/j.vaccine.2018.05.098_b0015","unstructured":"World Health Organization. Global tuberculosis report 2015. http:\/\/apps.who.int\/iris\/bitstream\/10665\/191102\/1\/9789241565059_eng.pdf [accessed 31.10.17]."},{"issue":"5","key":"10.1016\/j.vaccine.2018.05.098_b0020","first-page":"357","article-title":"Adverse events induced by BCG immunization in Taiwan","volume":"24","author":"Shue","year":"2008","journal-title":"Taiwan Epidemiol Bull"},{"issue":"9","key":"10.1016\/j.vaccine.2018.05.098_b0025","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.3201\/eid1509.081336","article-title":"Tokyo-172 BCG vaccination complications, Taiwan","volume":"15","author":"Jou","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.098_b0030","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3201\/eid2103.140789","article-title":"Mycobacterium bovis BCG\u2013associated osteomyelitis\/osteitis, Taiwan","volume":"21","author":"Chiu","year":"2015","journal-title":"Emerg Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.098_b0035","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3346\/jkms.2012.27.2.221","article-title":"Severe osteomyelitis as a complication of Tokyo-172 BCG vaccination","volume":"27","author":"Kwon","year":"2012","journal-title":"J Korean Med Sci"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.098_b0040","first-page":"66","article-title":"BCG adenitis\u2014need for increased awareness","volume":"18","author":"Govindarajan","year":"2011","journal-title":"Malaysian J Med Sci: MJMS"},{"key":"10.1016\/j.vaccine.2018.05.098_b0045","unstructured":"Tuberculosis. In: Kimberlin DW, Brady MT, et al. Red book: 2015 report of the Committee on Infectious Diseases, 30th ed. Elk Grove Village, IL: American Academy of Pediatrics; 2015: p. 805\u201331."},{"key":"10.1016\/j.vaccine.2018.05.098_b0050","unstructured":"World Health Organization. Department of vaccine and biologicals. Supplementary information on vaccine safety Part 2: Background rates of adverse events following immunization. WHO; 2000. http:\/\/apps.who.int\/iris\/handle\/10665\/66675 [accessed 31.10.17]."},{"issue":"5","key":"10.1016\/j.vaccine.2018.05.098_b0055","first-page":"446","article-title":"The natural course of non suppurative Calmette-Guerin bacillus lymphadenitis","volume":"21","author":"Anupam","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"36","key":"10.1016\/j.vaccine.2018.05.098_b0060","doi-asserted-by":"crossref","first-page":"4391","DOI":"10.1016\/j.vaccine.2015.07.039","article-title":"Management of Bacillus Calmette-Gu\u00e9rin osteomyelitis\/osteitis in immunocompetent children-A systematic review","volume":"33","author":"Lin","year":"2015","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.098_b0065","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/00006454-199402000-00007","article-title":"Osteitis after newborn vaccination with three different Bacillus Calmette-Gu\u00e9rin vaccines: twenty-nine years of experience","volume":"13","author":"Kr\u00f6ger","year":"1994","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2018.05.098_b0070","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1086\/513642","article-title":"Disseminated Bacille Calmette-Gu\u00e9rin disease after vaccination: case report and review","volume":"24","author":"Talbot","year":"1997","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.098_b0075","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1128\/JCM.35.3.566-569.1997","article-title":"PCR Identification of Mycobacterium bovis BCG","volume":"35","author":"Talbot","year":"1997","journal-title":"J Clin Microbiol"},{"issue":"1 Pt 1","key":"10.1016\/j.vaccine.2018.05.098_b0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1542\/peds.96.1.29","article-title":"The efficacy of Bacillus Calmette-Guerin vaccination of newborns and infants in prevention of tuberculosis: meta-analyses of the published literature","volume":"96","author":"Colditz","year":"1995","journal-title":"Pediatrics"},{"issue":"11","key":"10.1016\/j.vaccine.2018.05.098_b0085","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1093\/cid\/civ144","article-title":"Nonspecific (Heterologous) protection of neonatal BCG vaccination against hospitalization due to respiratory infection and sepsis","volume":"60","author":"de Castro","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.098_b0090","first-page":"84","article-title":"Complications of bacilli Calmette-Gu\u00e9rin (BCG) vaccination and immunotherapy and their management","volume":"1","author":"Grange","year":"1998","journal-title":"Commun Dis Public Health"},{"issue":"4","key":"10.1016\/j.vaccine.2018.05.098_b0095","first-page":"337","article-title":"Safety of the intradermal Copenhagen 1331 BCG vaccine in neonates in Durban, South Africa","volume":"79","author":"Jeena","year":"2001","journal-title":"Bull World Health Organ"},{"issue":"4","key":"10.1016\/j.vaccine.2018.05.098_b0100","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.tube.2007.11.010","article-title":"Adverse reactions to Mycobacterium bovis bacilli Calmette-Gu\u00e9rin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species","volume":"88","author":"Murphy","year":"2008","journal-title":"Tuberculosis"},{"key":"10.1016\/j.vaccine.2018.05.098_b0105","unstructured":"Lotte A, Wasz-Hockert O, Poisson N, Dumitrescu N, Verron M, Couvet E. BCG complications. Estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv Tuberculosis Res 1984; 21: p. 107\u2013193."},{"key":"10.1016\/j.vaccine.2018.05.098_b0110","unstructured":"Saovabha.com. Products of BCG Vaccine at QSMI. Queen Saovabha Memorial Institute. http:\/\/www.saovabha.com\/en\/product_vaccine.asp?nTopic=1."},{"issue":"8","key":"10.1016\/j.vaccine.2018.05.098_b0115","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1086\/521929","article-title":"Assessment of bacilli Calmette-Guerin vaccine reaction in HIV-exposed Thai infants","volume":"45","author":"Chokephaibulkit","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2018.05.098_b0120","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1016\/j.vaccine.2010.12.089","article-title":"Mycobacterium bovis (Bacille Calmette-Guerin) bacteremia in immunocopetent neonates following vaccination","volume":"29","author":"Thamthitiwat","year":"2011","journal-title":"Vaccine"},{"issue":"41","key":"10.1016\/j.vaccine.2018.05.098_b0125","doi-asserted-by":"crossref","first-page":"5470","DOI":"10.1016\/j.vaccine.2015.07.103","article-title":"Management and outcome of Bacillus Calmette-Guerin vaccine adverse reactions","volume":"33","author":"Venkataraman","year":"2015","journal-title":"Vaccine"},{"issue":"20","key":"10.1016\/j.vaccine.2018.05.098_b0130","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.1016\/j.vaccine.2004.07.052","article-title":"BCG vaccine-associated suppurative lymphadenitis","volume":"23","author":"Teo","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.05.098_b0135","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1056\/NEJMra1008049","article-title":"Tuberculosis in children","volume":"367","author":"Perez-Velez","year":"2012","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2018.05.098_b0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/INF.0000000000001081","article-title":"Orthopedic complications in former bacillus calmette-Guerin osteitis patients","volume":"35","author":"Poyhonen","year":"2016","journal-title":"Pediatr Infectious Dis J"},{"issue":"2","key":"10.1016\/j.vaccine.2018.05.098_b0145","first-page":"47","article-title":"BCG-osis after BCG vaccination in immunocompromised children: Case series and review","volume":"1","author":"Shahmohammadi","year":"2014","journal-title":"J Pediatr Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2018.05.098_b0150","first-page":"133","article-title":"Disseminated Mycobacterium bovis Infection after BCG vaccination","volume":"5","author":"Paiman","year":"2006","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"4","key":"10.1016\/j.vaccine.2018.05.098_b0155","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.jaci.2014.02.028","article-title":"BCG vaccination in SCID patients: complications, risks and vaccination policies","volume":"133","author":"Marciano","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"11","key":"10.1016\/j.vaccine.2018.05.098_b0160","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1002\/pbc.25588","article-title":"Successful Myeloblastive Bone Marrow Transplantation in an Infant With Wiskott-Aldrich Syndrome and Bacillus Calmette-Guerin Infection","volume":"62","author":"Yasutomi","year":"2015","journal-title":"Pediatr Blood cancer"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18307655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,24]],"date-time":"2022-08-24T18:54:17Z","timestamp":1661367257000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18307655"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":32,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S0264410X18307655"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.098","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and outcomes of Bacille Calmette-Gu\u00e9rin (BCG)-induced diseases following neonatal BCG Tokyo-172 strain immunization","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.05.098","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}